The sCelLiVE® Tissue Preservation Buffer is designed to maintain the integrity of fresh tissues without the need for chemical fixation, offering stable preservation for up to 72 hours and effectively simulating the natural physiological environment. This allows for high cell viability to be maintained even in sensitive samples. This sCelLiVE® Tissue Preservation Buffer enables gentle, prolonged preservation that is compatible with efficient dissociation.

Studies performed with brain tissue, both fresh and stored at 4°C for 24 and 72 hours, show that approximately 90% of cells remain alive after 72 hours in the Preservation Buffer, demonstrating its excellent capability to protect tissues over extended periods.

sCelLiVE Tissue Preservation Buffer

Key benefits of the sCelLiVE® Buffer

Simulation of the physiological environment, maintaining optimal conditions for cell survival for up to 72 hours. 
Gentle preservation, without altering viability or causing significant changes in cellular composition.
Versatility, compatible with practically all fresh and solid tissues used in biomedical research. 
Simple workflow, with a ready-to-use solution that avoids complex preparations or protocol optimization.

Area:

Omics, Single cell, Transcriptomics

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

ForenSeq® Kintelligence HT Kit

Amplicon-based library preparation kit covering 10,230 SNPs for the identification of individuals and human remains through kinship analysis. Its workflow combines library preparation from forensic samples, sequencing on MiSeq FGx and analysis in ForenSeq® Universal Analysis Software (UAS), which incorporates a local database for comparing genetic profiles. It also enables forensic investigative genetic genealogy (FIGG)…
Qiagen
Next Generation Sequencing (NGS)

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
Next Generation Sequencing (NGS)

SeqOne HRD Solution con Agilent SureSelect CD HRR17 Panel

HRD analysis solution combining low-coverage whole-genome sequencing (shallow/low-pass WGS) and a targeted gene panel to detect genomic instability, BRCA1/2 alterations and other genes related to homologous recombination. It is designed for laboratories wishing to implement HRD testing in-house with an automated, efficient and clinically validated workflow. Detailed Description SeqOne’s HRD solution combines shallow WGS and…
Agilent
Next Generation Sequencing (NGS)

OncoSELECT®

Comprehensive targeted liquid biopsy assay designed to support decision-making in oncology through the analysis of 74 clinically relevant genes. The solution encompasses everything from library preparation reagents to bioinformatics analysis, clinical interpretation and the generation of detailed reports. 3.- Detailed Description Operating principle OncoSELECT® is an advanced liquid biopsy panel based on circulating cell-free DNA…
OncoDNA
Next Generation Sequencing (NGS)